A practical reference on actin binding: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
This page was last updated on 2026-04-06 and is reviewed periodically as new material appears.
Thymosin beta-4 contains 43 amino acids and has a reported molecular mass near 4963 Da. The short fragment most often associated with the TB-500 label, an acetylated chain beginning LKKTETQ, has a reported mass near 889 Da, so the two are easily separated in analytical work. Mass spectrometry and amino acid analysis can confirm which material is present in a given sample. Statements treating TB-500 and thymosin beta-4 as interchangeable are therefore imprecise, even though the two appear together in much of the same literature.
Interest in the compound comes largely from studies of the parent protein, which participates in actin sequestration, cell migration and tissue repair processes. Whether a short fragment reproduces those activities is a separate question that remains open in the published record. Many summaries describe mechanisms by analogy to thymosin beta-4 rather than from direct measurements on the fragment. Claims about activity should be treated as provisional unless a cited study specifies the exact peptide, its purity and the assay used.
TB-500 is a laboratory label applied to a short synthetic peptide that is widely described as a fragment of thymosin beta-4, an actin-binding protein present in most mammalian cells. Suppliers and review articles usually present TB-500 as the N-terminal region of that protein, but the exact sequence attached to the name is not consistent across sources. Some product descriptions list a seven-residue chain; others use the label loosely for the parent protein itself. Because of that variation, any technical discussion of TB-500 needs to state which sequence is meant.
Lyophilized peptide powder is normally held desiccated at −20 °C, with −80 °C used for longer storage periods. Allowing a sealed vial to reach room temperature before opening is standard practice, because condensation forming on cold powder introduces moisture. Once dissolved, solutions are typically kept cold and shielded from light. Repeated freeze-thaw cycles are avoided because they encourage aggregation and gradual loss of material. These conventions are general to synthetic peptides rather than unique to any one sequence.
Purity and identity are separate measurements and are often confused. Reverse-phase high-performance liquid chromatography, usually with ultraviolet detection near 214 nanometres, reports the share of total peak area belonging to the target compound. Mass spectrometry by electrospray or matrix-assisted laser desorption then checks whether the observed mass matches the expected sequence. Neither measurement alone shows that a vial holds the intended peptide. Peptide content, meaning the fraction of vial mass that is genuine peptide rather than counter-ion, water or residual acid, is reported separately and is frequently lower than the stated purity figure.
| Property | Value | Notes |
|---|---|---|
| Physical form | Lyophilised powder | Sealed vial; reconstituted before laboratory use |
| Appearance | White to off-white solid | Visual descriptor used on certificates of analysis |
| Solubility class | Water-soluble | Dissolves in water and aqueous buffers |
| Reported mass, fragment | Near 889 Da | Value depends on the stated sequence |
| Reported mass, parent protein | Near 4963 Da | 43-residue thymosin beta-4 |
Animal work has examined the peptide in models of cardiac injury, skin wounding, and corneal repair, with reported outcomes covering cell migration, inflammatory cell influx, and tissue remodeling. Several of those experiments used the full-length protein or longer fragments instead of the seven-residue sequence, which makes direct comparison between reports difficult. Results are generally described as tissue-dependent, and effect sizes vary considerably across laboratories. Independent replication is uneven, so the overall picture is incomplete rather than settled.
Controlled human trials of the short fragment are scarce. Much of what appears in review articles is extrapolated from animal models or from studies of the parent protein, and literature searches return a larger body of cardiac and ophthalmic work on thymosin beta-4 than on the abbreviated peptide. Regulatory treatment differs by jurisdiction, and in several countries the material is handled as a research chemical rather than an approved therapeutic. Statements about human benefit should be read as provisional.
Biological interest in this peptide centers on its relationship to actin dynamics. Thymosin beta-4 binds monomeric actin through an LKKTET motif, and a short sequence carrying that motif can compete with other actin-binding proteins in cell-free preparations. Investigators propose that such competition shifts the balance between filament assembly and disassembly, which in turn affects how readily a cell extends protrusions and migrates. Most of the supporting observations come from cultured cells and purified protein systems rather than from intact organisms.
TB-500 is a synthetic peptide preparation marketed under a name derived from thymosin beta-4, a 43-residue actin-binding protein first isolated from thymus tissue. The full-length protein has a reported molecular mass near 4963 Da, while material sold as TB-500 is often described as a fragment containing the actin-binding motif LKKTETQ. Because suppliers use the name inconsistently, published sources sometimes refer to the same label as a fragment, a synthetic copy, or a related analog. This naming ambiguity complicates direct comparison of reports across studies.
Laboratory work on thymosin beta-4 describes binding to monomeric actin and effects on cell migration, angiogenesis, and inflammatory signaling in cultured cells. Animal models have examined skin, corneal, and cardiac repair after injury, with outcomes reported mainly in preclinical literature. Most of that evidence concerns the parent protein rather than preparations labelled TB-500, so extrapolation from animal findings to a specific commercial product remains uncertain. Whether the two behave identically in living systems has not been established in controlled human studies.
No major regulatory agency has approved TB-500 for therapeutic use, and it holds no pharmacopoeial monograph. The name appears on the World Anti-Doping Agency prohibited list within the class covering peptide hormones, growth factors, and related substances. Detection in doping control relies on mass spectrometric methods applied to urine, often after preparation steps that concentrate the analyte. Discussion of TB-500 therefore clusters in biochemistry, sports medicine, and anti-doping literature rather than in registered clinical trials.
Proposed activity centers on actin sequestration and on the movement of cells during repair processes. In cell culture and animal models, the fragment has been associated with migration, tube formation, and tissue remodeling. These observations are frequently described as preliminary, because most published work uses rodent or in vitro systems rather than controlled human trials. Whether the short fragment reproduces the effects of the full protein remains an open question, and the relationship between dose, route, and measured outcome is not well characterized.
The compound circulates in the literature as a research reagent rather than an approved therapeutic. Regulatory agencies in several countries have not authorized it for medical use, and sporting bodies list related thymosin beta-4 peptides among prohibited substances. Suppliers typically market it with a purity figure and a certificate of analysis, while peer-reviewed clinical reports remain sparse. Discussions therefore often separate laboratory findings from anecdotal reports, and reviewers tend to note the small size and methodological limits of the available studies.
TB-500 refers to a synthetic peptide fragment derived from the actin-binding region of thymosin beta-4, a protein present in most mammalian cells. The full protein contains forty-three amino acids, while the commonly sold fragment is a much shorter acetylated sequence, often cited as LKKTETQ. The fragment retains part of the actin-binding motif but lacks the remainder of the parent protein. Material sold under this name is usually lyophilized powder intended for laboratory research, and it is not a finished pharmaceutical product.
TB-500 is a research peptide whose sequence matches residues 17 to 23 of thymosin beta-4, a 43-residue protein present in most mammalian cells. The chain is seven amino acids long, written as LKKTETQ, and is normally supplied with an acetyl group on the N-terminus. Suppliers list it as a lyophilised powder under the code name TB-500, and the same sequence appears elsewhere in catalogues as the thymosin beta-4 actin-binding fragment. The label is commercial rather than systematic, so no single authority fixes exactly what TB-500 denotes.
Thymosin beta-4 was isolated from calf thymus in the early 1980s and later characterised as an abundant intracellular actin-sequestering protein. Interest in short synthetic fragments grew once the actin-binding motif had been mapped to the middle of the sequence. TB-500 came out of that line of work as a truncated analogue rather than a natural isolate, and it is now sold mainly to laboratories. Published studies on the fragment have been largely in vitro or in animal models, and controlled human trials remain sparse, so claims about effects in people rest on extrapolation.
Literature and online discussion often conflate TB-500 with full-length thymosin beta-4, even though the two differ in size and are not interchangeable in analytical terms. The fragment is produced by solid-phase peptide synthesis, and the product is a defined seven-residue chain rather than a biological extract. Because the term is a trade-style label, two vendors may supply materials of the same nominal sequence but different counter-ion content, purity, or water content. Comparisons across studies are therefore difficult unless the exact sequence and purity are reported.
Hyperprolactinaemia (also spelled hyperprolactinemia) is a condition characterized by abnormally high levels of prolactin in the blood. In women, normal prolactin levels average to about 13 ng/mL, while in men, they average 5 ng/mL. The upper normal limit of serum prolactin is typically between 15 and 25 ng/mL for both men and women. Levels exceeding this range indicate hyperprolactinemia. Prolactin (PRL) is a peptide hormone produced by lactotroph cells in the anterior pituitary gland. It plays a vital role in lactation and breast development. Hyperprolactinemia, characterized by abnormally high levels of prolactin, may cause galactorrhea (production and spontaneous flow of breast milk), infertility, and menstrual disruptions in women. In men, it can lead to hypogonadism, infertility and erectile dysfunction. Prolactin is crucial for milk production during pregnancy and lactation. Together with estrogen, progesterone, insulin-like growth factor-1 (IGF-1), and hormones from the placenta, prolactin stimulates the proliferation of breast alveolar elements during pregnancy. However, lactation is inhibited during pregnancy due to elevated estrogen levels. After childbirth, the rapid decline in estrogen and progesterone levels allows lactation to begin. Unlike most tropic hormones released by the anterior pituitary gland, prolactin secretion is primarily regulated by hypothalamic inhibition rather than by negative feedback from peripheral hormones.
== Function == Protein kinase function has been evolutionarily conserved from Escherichia coli to Homo sapiens. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation. Phosphorylation usually results in a functional change of the target protein by changing structure, dynamics, enzyme activity, cellular location, or association with other proteins.
Unlike her slender sister, Roseanne has always had difficulty controlling her weight, inspiring an episode in which she and Dan go on a diet. Her bad dietary habits are shown to be symptomatic of her emotional health, often overeating fattening foods for comfort when stressed or merely for pleasure and reward. Roseanne is happily married, though Dan's laziness in performing household chores occasionally causes friction. A loving mother, she raises her children to be independent, individualistic, and self-sufficient. She is also close to Jackie, who is neurotic, and insecure, and has many short-term romantic relationships. Her relationship with her parents is more complicated. Her passive-aggressive mother, Bev, dotes on her two daughters, but she is often critical, interfering, and sometimes pits Roseanne and Jackie against each other by exploiting their individual insecurities. Roseanne's father, Al, initially portrayed as jovial and easy-going, is later revealed as a philandering husband and an overly-strict father who used corporal punishment to discipline his daughters over minor offenses, leaving Roseanne unable to trust men, including Dan, for many years. Roseanne later co-owns a moderately successful restaurant, the Lanford Lunch Box, along with Jackie, and her friend Nancy. She and Jackie reluctantly accept their mother Bev as a fourth partner when more money is needed to open the business. Her annoying former Rodbell's luncheonette boss, Leon Carp, becomes a partner after Bev sells him her share as retaliation against Jackie and Roseanne for diminishing her role.
Sources: en.wikipedia.org
== Wealth inequalities == Between 1998 and 2015, the wealth gap between men and women in France increased from 9% to 16%. This disparity is partially linked to the types of assets inherited. Women are more likely to receive liquid financial compensation, while men more frequently inherit appreciating structural assets such as real estate or businesses. Additional contributing factors include greater economic vulnerability for women following separation or divorce. Approximately 30% of women, compared to 3% of men, experience a decline in financial stability post-separation. This is partly due to the conversion of alimony from regular annuities to lump-sum payments in the early 2000s. The average amount dropped from €93,000 to €25,000. Child support calculations are typically based on the payer's financial capacity rather than the recipient's needs. As women more often have custody, they are more likely to rely on social support to maintain living standards. Property ownership can also become difficult to retain. In situations involving domestic violence among homeowners in heterosexual couples, women who leave the shared residence may do so without negotiating their share, often in order to expedite the separation process.
==== Gás do Povo ==== In November 2025, the Gás do Povo program began, replacing Auxílio Gás. The program guarantees the free refill of the LPG cylinder (13 kg) at retailers accredited by the government. The measure aims to promote access to LPG (Liquefied Petroleum Gas), avoiding the use of precarious alternatives such as firewood, charcoal, and kerosene, which can expose families to toxic smoke, chronic respiratory diseases, and the constant danger of burns. The benefit is intended for families registered in the Cadastro Único (CadÚnico), with an income of up to half the minimum wage, with priority given to those who receive Bolsa Família. Caixa Econômica Federal is responsible for the operationalization of the benefit, being in charge of distributing the refill vouchers, registering participating retailers, and validating the beneficiaries' means of access.
The "Cave of the Sixteen sword bearers" ("Höhle der Schwertträger", 十六带剑者窟) is a famous cave with a series of murals showing swordsmen wearing caftans and armed with long sword and daggers. These murals have been carbon dated to 432–538 CE. The swordsmen have also been dubbed the "Tocharian donors". The interpretations of the nationality or ethnicity of the donors have varied. Some authors claim that the donors are indeed Tocharians, an elusive people of the Tarim Basin who spoke the well-documented Tocharian language, the easternmost Indo-European language. According to this thesis, the donors in the murals are of the Indo-European type, wearing Iranian-style clothes and reddish hair. A more recent interpretation is that the sword-bearers are actually Hephthalites, who are known to have occupied the Tarim Basin from 490 to 560 CE, precisely at the time the paintings were made. Kucha was specifically part of their dominion between 502 and 556 CE. The clothing style, the iconography and the physiognomy of the donors are said to be extremely close to those depicted in the paintings of Tokharistan (Bactria), the center of Hephthalite power, at sites such as Balalyk tepe or Dilberjin Tepe. In particular, the coat with single folded lapel is considered as a result of Hephthalite influence, whereas traditional Kuchean coats had two lapels. At present, the most prevalent opinion among academics seems to be that the Hephthalites were initially of Turkic origin. Similar donors can be seen in the Kumtura Caves.
Mass spectrometry has been successfully used to identify changes in the composition of the adhesome upon perturbation. Schiller et al. as well as Kuo et al. examined the effect of inhibition of myosin contractility on the integrin adhesome composition and found LIM domain proteins and beta-PIX to be tension sensitive. Gou et al. found little change in the cadherin adhesome after calcium depletion from the media, which essentially abrogates cell-cell adhesion. Reinhard Fassler and co-workers used proteomics on specifically engineered cell lines to distinguish between the adhesome of β1- and αv-class integrins.
Sources: en.wikipedia.org
=== Antihyperglycemic agents === The term "biguanidine" often refers specifically to a class of drugs that function as oral antihyperglycemic drugs used for diabetes mellitus or prediabetes treatment. Examples include:
=== Russia === Russian authorities stated that Russia reacted to the numerous casualties among the South Ossetian civilian population caused by the Georgian attack. According to Russia, its aim was defence of Russian citizens and Russian peacekeepers in South Ossetia. According to the Russian military, the Russian peacekeepers in South Ossetia suffered casualties on August 8. Initially, Russia went as far as accusing Georgia of committing "genocide" against Ossetians. Defending Russia's decision to launch attack in uncontested Georgia, Russian Foreign Minister Sergey Lavrov said that Russian targeting of military infrastructure used for the Georgian attack was legally warranted. It was claimed that Georgia codenamed its attack Operation "Clear Field". Russia also claimed that Georgia was planning to launch a two-day Operation "Rock" to retake Abkhazia. Russia codenamed its military action "Operation to Force Georgia to Peace". The term "enforcing to peace" for describing the war against Georgia allegedly has been coined by General Anatoliy Nogovitsyn. Three years after the August War, President of Russia Dmitry Medvedev stated that NATO would have admitted Post-Soviet states if Russia had not invaded Georgia. "If you...had faltered back in 2008, the geopolitical situation would be different now," Medvedev declared at a Vladikavkaz military base. In response, the Georgian authorities claimed that Medvedev had admitted that Russia started the war with Georgia.
== High-level details == Good manufacturing practice guidelines provide guidance for manufacturing, testing, and quality assurance in order to ensure that a manufactured product is safe for human consumption or use. Many countries have legislated that manufacturers follow GMP procedures and create their own GMP guidelines that correspond with their legislation. All guidelines follow a few basic principles:
Sources: en.wikipedia.org
No. TB-500 is a trade-style label used for a synthetic peptide described as a fragment of thymosin beta-4, while thymosin beta-4 is the full 43-residue protein. The two differ in size and are not interchangeable terms in analytical work.
Naming for research peptides is not standardised, and suppliers sometimes apply the same label to different chain lengths. Certificates of analysis and mass data are the practical way to determine what a given lot contains.
The fragment commonly cited under this label is reported near 889 Da, and the parent protein near 4963 Da. Reported values shift with the exact sequence and with residual counter-ions or water in the sample.
Desiccated storage at −20 °C is conventional, with −80 °C for extended periods. Vials should be warmed to room temperature before opening to prevent condensation on the powder.